Market News & Trends
AB Biosciences & Shire Enter Development & Commercialization Agreement
AB Biosciences, Inc. and Shire plc recently announced they have entered into an agreement granting Shire an exclusive worldwide license to develop and commercialize AB…
Fibrocell Announces FDA Allowance to Initiate Pediatric Enrollment in Phase 1/2 Clinical Trial
Fibrocell Science, Inc. recently announced that it obtained allowance from the US FDA to initiate enrollment of pediatric patients in the Phase 2 portion of…
Lupin Receives Innovator Award From BioNJ
Symbiomix, a Lupin Company, received an Innovator Award from BioNJ, New Jersey’s trade association for the biotechnology community. Leadership from the company was on hand…
Syndax Announces Immuno-Oncology Clinical Trial Collaboration With AstraZeneca
Syndax Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, recently announced a new clinical collaboration with AstraZeneca to evaluate the…
Evonetix Raises $12.3 Million to Advance Gene Synthesis Platform
Evonetix recently announced it has completed a $12.3-million financing to advance the development of its technology. The financing was co-led by DCVC (Data Collective) of…
LifeArc & Milner Therapeutics Institute Announce Partnership in Artificial Intelligence & Machine Learning
LifeArc and the Milner Therapeutics Institute at the University of Cambridge, recently announced a new partnership to identify and validate new drug targets in immuno-oncology…
Hovione Strengthens Inhalation Services Portfolio
Hovione recently announced that a new MG2 Tekna Precision Capsule filling unit is now online in its Portugal facilities. This investment reinforces Hovione’s Services portfolio…
Cynata Announces Encouraging Results; DSMB Recommendation Next Stage
Australian stem cell and regenerative medicine company, Cynata Therapeutics, recently announced that the independent Data Safety Monitoring Board (DSMB) has recommended that Cynata’s clinical trial…
Avacta & Oncosec to Collaborate on Innovative Gene Delivery
Avacta & Oncosec to Collaborate on Innovative Gene Delivery Avacta Group plc and OncoSec Medical Incorporated recently announced they have entered into a research collaboration…
BioCryst & Idera Announce Merger to Combine Capabilities
BioCryst Pharmaceuticals, Inc. and Idera Pharmaceuticals, Inc. recently announced they have signed a definitive merger agreement to form a new enterprise focused on the development…
Voyager Therapeutics Announces FDA Clearance of IND Application for VY-AADC
Voyager Therapeutics, Inc. recently announced the US FDA has cleared the Investigational New Drug (IND) application for VY-AADC, allowing the company to formally initiate clinical…
RedHill Biopharma Announces Final Results from Phase II Study
RedHill Biopharma Ltd. recently announced top-line final results from the Phase II clinical study with BEKINDA 12 mg (RHB-102) for the treatment of diarrhea-predominant irritable…
Biolog Announces Mitochondrial Assay Breakthrough
Biolog, Inc. recently announced the launch of a new product line that enables a comprehensive scan of mitochondrial function. Better technology for measuring mitochondrial function…
PPD & Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug Development
Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), and Quotient Sciences (Quotient), a drug development services organization, recently announced a new…
Marina Biotech Announces Drug Development & Licensing Agreement With Autotelic Bio
Marina Biotech, Inc. recently announced it has entered into a binding agreement with Autotelic Bio Inc., to enter into a license of Marina’s IT-103 clinical…
Avacta Group Announces Positive Outcome of Proof-of-Concept Study
Avacta Group plc recently announced its initial study with Glythera Limited, the developer of next-generation antibody drug conjugates, has concluded successfully. Following this study, the…
OWKIN Closes $11-Million Financing for AI in Drug Development
OWKIN, a predictive analytics company that utilizes transfer learning to accelerate drug discovery and development, recently announced an $11-million Series A funding round, led by…
Colorcon Transforms the Sugar Coating Process With a New Opadry System
Colorcon Inc. recently announces an exciting process development for sugar coated pharmaceutical tablets with the launch of Opadry® SGR, Rapid Sugar Film Coating System. This…
Sanofi to Acquire Bioverativ for $11.6 Billion
Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into a definitive agreement under which…
Next Breath Announces Injectable Extractable & Leachable Services
Next Breath, a division of AptarGroup, is pleased to announce the extension of their cGMP analytical services to include development services for injectable delivery systems,…
